Non–adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke

[1] Cleemput undefined(2002)undefined Lancet 359 2129-undefined

[2] Donovan undefined(1995)undefined Int J Technol Assess Health Care 11 443-undefined

[3] EAFT undefined(1993)undefined Lancet 342 1255-undefined

[4] Gencheva undefined(2004)undefined Neuroepidemiology 23 61-undefined

[5] Hamann undefined(2003)undefined Cerebrovasc Dis 15 282-undefined

[6] Hillen undefined(2000)undefined Stroke 31 469-undefined

[7] Mushlin undefined(1977)undefined Arch Intern Med 137 318-undefined

[8] Rojas–Fernandez undefined(1999)undefined Can J Cardiol 15 291-undefined

[9] Sappok undefined(2001)undefined Stroke 32 1884-undefined

[10] Schroeder undefined(2004)undefined Arch Intern Med 164 722-undefined

[1] Cleemput undefined(2002)undefined Lancet 359 2129-undefined

[2] Donovan undefined(1995)undefined Int J Technol Assess Health Care 11 443-undefined

[3] EAFT undefined(1993)undefined Lancet 342 1255-undefined

[4] Gencheva undefined(2004)undefined Neuroepidemiology 23 61-undefined

[5] Hamann undefined(2003)undefined Cerebrovasc Dis 15 282-undefined

[6] Hillen undefined(2000)undefined Stroke 31 469-undefined

[7] Mushlin undefined(1977)undefined Arch Intern Med 137 318-undefined

[8] Rojas–Fernandez undefined(1999)undefined Can J Cardiol 15 291-undefined

[9] Sappok undefined(2001)undefined Stroke 32 1884-undefined

[10] Schroeder undefined(2004)undefined Arch Intern Med 164 722-undefined